Literature DB >> 10733933

Role of hepatocyte nuclear factor 1alpha and 1beta in the transcriptional regulation of human dipeptidyl peptidase IV during differentiation of Caco-2 cells.

R H Erickson1, R S Lai, Y S Kim.   

Abstract

Caco-2 cells undergo differentiation to an enterocytic-like cell when maintained in a post-confluent state for 1-2 weeks. During this period Caco-2 cells begin to express high levels brush border membrane associated enzymes such as dipeptidyl peptidase IV. Using the dipeptidyl peptidase IV gene promoter in electrophoretic mobility shift assays, we have shown for the first time that levels of hepatocyte nuclear factor 1alpha increase three- to fourfold during Caco-2 cell differentiation. Transient cotransfection experiments with 3T3 cells using dipeptidyl peptidase IV promoter constructs and expression vectors containing hepatocyte nuclear factor 1alpha and beta show that the ratio of alpha and beta modulates reporter gene expression. These results suggest that the increase in levels of hepatocyte nuclear factor 1alpha that occur during intestinal cell differentiation, are important for expression of dipeptidyl peptidase IV and other intestinal proteins. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733933     DOI: 10.1006/bbrc.2000.2420

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Small bowel review: Normal physiology, part 1.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  The mouse alpha-albumin (afamin) promoter is differentially regulated by hepatocyte nuclear factor 1α and hepatocyte nuclear factor 1β.

Authors:  Hua Liu; Hui Ren; Brett T Spear
Journal:  DNA Cell Biol       Date:  2010-10-27       Impact factor: 3.311

3.  Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines.

Authors:  Masako Abe; Pamela A Havre; Yasuyo Urasaki; Kei Ohnuma; Chikao Morimoto; Long H Dang; Nam H Dang
Journal:  BMC Cancer       Date:  2011-02-01       Impact factor: 4.430

Review 4.  Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials.

Authors:  Jixin Zhong; Quan Gong; Aditya Goud; Srividya Srinivasamaharaj; Sanjay Rajagopalan
Journal:  J Diabetes Res       Date:  2015-05-14       Impact factor: 4.011

5.  Identification of senescent cell surface targetable protein DPP4.

Authors:  Kyoung Mi Kim; Ji Heon Noh; Monica Bodogai; Jennifer L Martindale; Xiaoling Yang; Fred E Indig; Sandip K Basu; Kei Ohnuma; Chikao Morimoto; Peter F Johnson; Arya Biragyn; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Genes Dev       Date:  2017-09-06       Impact factor: 11.361

Review 6.  Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function.

Authors:  Quan Gong; Sanjay Rajagopalan; Jixin Zhong
Journal:  Int J Cardiol       Date:  2015-06-27       Impact factor: 4.164

7.  The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation.

Authors:  Sepideh Fallah; Jean-François Beaulieu
Journal:  Cells       Date:  2020-08-13       Impact factor: 6.600

8.  Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.

Authors:  Laura R Moffitt; Maree Bilandzic; Amy L Wilson; Yiqian Chen; Mark D Gorrell; Martin K Oehler; Magdalena Plebanski; Andrew N Stephens
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.